Colette Doerr-Harim

University Hospital Ulm

Papers

1

Total Citations

5

H-Index

1

About

Colette Doerr-Harim is a leading clinical researcher in upper gastrointestinal oncology, specializing in the surgical management of esophageal cancer. Her work focuses on refining minimally invasive esophagectomy techniques to reduce the significant morbidity associated with this complex, two-cavity procedure. She is best known for her central role in the MICkey trial, a landmark multicenter randomized controlled trial comparing total minimally invasive keyhole esophagectomy to hybrid approaches. Her 2023 study protocol for this trial, which has already garnered early citations, establishes the rigorous framework needed to determine whether a fully endoscopic approach can meaningfully lower complication rates and improve recovery for patients with esophageal cancer—the sixth leading cause of cancer death worldwide. By systematically evaluating surgical innovations through high-quality evidence, Doerr-Harim is helping to define new standards of care that directly impact patient outcomes. Her work bridges the gap between technical surgical advancement and clinical reality, making her a key figure in the ongoing effort to make esophagectomy safer and more tolerable for patients.

Research Focus

Key Achievements

1
H-Index
1
Papers
5
Total Citations
5
Avg Citations/Paper
🏆 Most Cited Paper
Overall morbidity after total minimally invasive keyhole oesophagectomy versus hybrid oesophagectomy (the MICkey trial): study protocol for a multicentre randomized controlled trial
5 citations · 2023
📈 Most Prolific Year: 2023 (1 Papers)
🤝 Key Collaborators: 13
🏛 Institutions: University Hospital Ulm

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 12 days ago